SANOFI GENZYME, the specialty care division of global healthcare leader Sanofi, focuses on advanced therapeutic solutions in areas such as rheumatology and orthopedics. The company’s flagship osteoarthritis product, SYNVISC, is a high-performance viscosupplement that mimics natural synovial fluid to relieve joint pain and improve mobility.